Strategies to Overcome Downstream Bottlenecks in Cell and Gene Therapy
Posted on September 27, 2018
Abstract The success of gene and cell therapy in clinical trials and recent FDA approval demands for robust platforms of upstream and downstream processes for viral vector production. The upstream stage comprises of processes leading to vector packaging and downstream comprises of processes for vect...
To read the full article and other articles in this issue, please register for a free account or log in.
Subscribe to our FREE newsletter